Both substances affect blood glucose regulation and gastrointestinal function, creating potential risks including hypoglycemia, worsened side effects, and impaired treatment outcomes
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL PACKAGE LABEL MOUNJARO KwikPen 10 mg per dose (40 mg/2.4 mL [16.7 mg/mL]) NDC 0002-3433-11 Rx Only Mounjaro KwikPen (tirzepatide) injection 10 mg per dose 40 mg/2.4 mL (16.7 mg/mL) 1 Pen with 4 doses of 10 mg TURN THE DOSE KNOB ALL THE WAY UNTIL YOU SEE A Figure
Nausea is most frequently reported issue, and it tends to improve as your body adjusts to medication over first few weeks
As GLP 1 receptor activation increases step by step, the brain and digestive tract recalibrate together
1 Introduction Depression, as a common mental disorder, seriously endangers human physical and mental health (Paykel, 2008)